v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 01, 2025
Feb. 03, 2024
Jan. 28, 2023
Operating activities      
Net income $ 1,201,118 $ 1,291,005 $ 1,242,408
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 267,042 243,840 241,372
Non-cash lease expense 310,636 332,754 301,912
Deferred income taxes (43,328) 30,575 15,653
Stock-based compensation expense 42,787 48,246 43,044
Loss on disposal of property and equipment 11,566 11,419 6,688
Change in operating assets and liabilities:      
Receivables (15,395) (8,517) 34,260
Merchandise inventories (226,078) (138,685) (104,233)
Prepaid expenses and other current assets (13,515) 14,648 (19,432)
Income taxes 34,772 45,367 (45,182)
Accounts payable 30,297 (20,873) 8,309
Accrued liabilities 6,303 (62,238) 48,249
Deferred revenue 63,994 41,914 41,098
Operating lease liabilities (333,835) (338,105) (324,500)
Other assets and liabilities 2,241 (15,084) (7,731)
Net cash provided by operating activities 1,338,605 1,476,266 1,481,915
Investing activities      
Capital expenditures (374,458) (435,267) (312,126)
Other investments (8,631) (6,158) (2,458)
Net cash used in investing activities (383,089) (441,425) (314,584)
Financing activities      
Borrowings from credit facility 199,700 195,400  
Payments on credit facility (199,700) (195,400)  
Repurchase of common shares (1,003,328) (995,738) (900,033)
Stock options exercised 12,339 12,176 46,011
Purchase of treasury shares (23,761) (22,562) (6,992)
Debt issuance costs (4,159)    
Net cash used in financing activities (1,018,909) (1,006,124) (861,014)
Net increase (decrease) in cash and cash equivalents (63,393) 28,717 306,317
Cash and cash equivalents at beginning of year 766,594 737,877 431,560
Cash and cash equivalents at end of year 703,201 766,594 737,877
Supplemental information      
Cash paid for interest 4,159 3,327 2,138
Income taxes paid, net of refunds 386,059 328,215 429,846
Non-cash capital expenditures 22,561 61,757 $ 69,591
Repurchase of common shares in accrued liabilities $ 14,967 $ 4,297  

Source